SCHEMBL10468698

SCHEMBL10468698

COc1cccc(C2(c3cccc(OC)c3)CC2/C=C/C(=O)O)c1

nearest known ligand 0.51

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
POLB P06746 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
CRHBP P24387 1/20 0.46
CRHR2 Q13324 1/20 0.46
KDM1A O60341 1/20 0.46
ADAM17 P78536 1/20 0.45
GRIN2B Q13224 8/20 0.45
ALDH1A1 P00352 1/20 0.42
HCAR2 Q8TDS4 1/20 0.41
FOS P01100 1/20 0.39
JUN P05412 1/20 0.39
BCHE P06276 1/20 0.39
MAOB P27338 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10468073 1.00 MEN1 (0.51) MEN1KMT2APOLBSMN1; SMN2CRHBP
SCHEMBL10469701 1.00 MEN1 (0.51) MEN1KMT2APOLBSMN1; SMN2CRHBP
SCHEMBL10468074 1.00 MEN1 (0.51) MEN1KMT2APOLBSMN1; SMN2CRHBP
SCHEMBL10467463 0.80 KDM1A (0.53) MEN1KMT2APOLBSMN1; SMN2CRHBP
SCHEMBL10467987 0.80 LMNA (0.41) MEN1KMT2APOLBGRIN2BALDH1A1
SCHEMBL10467989 0.80 LMNA (0.41) MEN1KMT2APOLBGRIN2BALDH1A1
SCHEMBL10467452 0.80 LMNA (0.41) MEN1KMT2APOLBGRIN2BALDH1A1
SCHEMBL10467453 0.80 LMNA (0.41) MEN1KMT2APOLBGRIN2BALDH1A1
SCHEMBL10467674 0.80 LMNA (0.41) MEN1KMT2APOLBGRIN2BALDH1A1
SCHEMBL10467434 0.80 LMNA (0.41) MEN1KMT2APOLBGRIN2BALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4927826-A Cycloproylpropenamides useful as platelet activing factor (PAF) antagonists HOFFMAN-LA ROCHE INC. (US) 1990-05-22 US disclosed
US-4786646-A PLATELET ACTIVATING FACTOR ANTAGONISTS HOFFMANN-LA ROCHE INC. (US) 1988-11-22 US disclosed